Cactohealth
Cacto Health develops MyLymphCare, the first at-home monitoring solution designed for breast cancer-related lymphedema. This system utilizes bioimpedance spectroscopy to enable early detection of fluid changes, allowing for timely intervention. By shifting monitoring to the home, the company supports patient independence and helps healthcare systems manage chronic lymphedema costs.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Cacto Health develops MyLymphCare, the first at-home monitoring solution designed for breast cancer-related lymphedema. This system utilizes bioimpedance spectroscopy to enable early detection of fluid changes, allowing for timely intervention. By shifting monitoring to the home, the company supports patient independence and helps healthcare systems manage chronic lymphedema costs.